Zelnorm, an agonist of 5-Hydroxytryptamine 4-receptor, acts as a potential antitumor drug by targeting JAK/STAT3 signaling.
Zhang L, Song Q, Zhang X, Li L, Xu X, Xu X, Li X, Wang Z, Lin Y, Li X, Li M, Su F, Wang X, Qiu P, Guan H, Tang Y, Xu W, Yang J, Zhao C.
Zhang L, et al. Among authors: song q.
Invest New Drugs. 2020 Apr;38(2):311-320. doi: 10.1007/s10637-019-00790-8. Epub 2019 May 14.
Invest New Drugs. 2020.
PMID: 31087223